Sezgin, Canfeza <br/><br/>
Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors.  [electronic resource] 

 -  Scandinavian journal of gastroenterology  Dec 2005 
 - 1486-92 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0036-5521 
<br/><br/><label>Standard No.: </label>10.1080/00365520510023819  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Carcinoma--drug therapy<br/>Deoxycytidine--analogs & derivatives<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Health Status Indicators<br/>Humans<br/>Male<br/>Middle Aged<br/>Pancreatic Neoplasms--drug therapy<br/>Retrospective Studies<br/>Survival Rate<br/>Treatment Outcome<br/>Gemcitabine